AIRO Group Holdings, Inc. Common Stock
NASDAQ:AIROAerospace & Defense
+$0.43 today
- Market cap
- $141.13M
- Beta
- 1.82
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$0.56
Volume 0.28M
Average 0.62M
AIRO Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
AIRO Group Holdings, Inc. Common StockNASDAQ: AIRO
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue dips below year-ago levels
Q1 FY2026 cost of revenue of $6.54M fell 13.3% year over year, behind the +14.8% change in trailing-twelve-month cost of revenue. Sequentially, it fell 59.0% from the prior quarter. Over 3 fiscal years it compounded at +41.2% a year.
Context
- Cost of revenue amounted to 40.1% of revenue in FY2025, up 7.2 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -13.3% toward the trailing-twelve-month pace of +14.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 36.49M USD
- Year-over-year change
- +27.5%
- 4-year CAGR
- +44.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 36.49M | +27.5% |
| FY2024 | 2024-12-31 | 28.62M | +56.0% |
| FY2023 | 2023-12-31 | 18.34M | +41.6% |
| FY2022 | 2022-12-31 | 12.95M | +56.0% |
| FY2021 | 2021-12-31 | 8.3M | — |
Cost of Revenue vs competitors
How AIRO compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +14.8% is the 2nd highest of 10, against a peer median of +6.0%.
- Cost of revenue amounts to 40.3% of revenue for AIRO, versus a peer median of 69.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.04B USD | -7.9% | +1.3% | 56.3% | |
| LTM Mar 2026 | $792.89M USD | +13.5% | +1.0% | 93.8% | |
| LTM Apr 2026 | $382.74M USD | +10.2% | +5.6% | 73.1% | |
| LTM Feb 2026 | $271.99M USD | -1.9% | -3.3% | 69.3% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $202.09M USD | +6.0% | +8.6% | 79.5% |
| LTM Mar 2026 | $96.61M USD | -10.5% | -9.6% | 52.8% | |
| LTM Mar 2026 | $50.63M USD | +14.1% | +10.4% | 69.1% | |
| LTM Mar 2026 | $48.59M USD | +0.2% | -17.6% | 10.9% | |
| LTM Feb 2026 | $48.03M USD | +32.6% | +28.9% | 39.7% | |
| LTM Mar 2026 | $35.49M USD | +14.8% | +41.2% | 40.3% | |
| LTM Mar 2026 | £15.22M GBP | — | -10.7% | — | |
| Peer median (excluding AIRO) | — | +6.0% | +1.1% | 69.1% | |
Competitors are the stored peer set for AIRO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 11.78M | 17.08M | 43.25M | 86.94M | 90.91M |
| Cost of Revenue | 8.3M | 12.95M | 18.34M | 28.62M | 36.49M |
| Gross Profit | 3.48M | 4.13M | 24.91M | 58.32M | 54.42M |
| Gross Margin | 29.5% | 24.2% | 57.6% | 67.1% | 59.9% |
| Research & Development | 1.15M | 9.3M | 11.87M | 13.13M | 17.92M |
| Selling, General & Admin | 4.9M | 21.83M | 22.98M | 24.62M | 65.26M |
| Operating Expenses | 6.05M | 31.13M | 34.85M | 75.75M | 83.18M |
| Depreciation & Amortization | 1.05M | 10.05M | 13.25M | 12.99M | 12.59M |
| EBITDA | (16.07M) | (23.1M) | (14.78M) | (2.27M) | 25.33M |
| EBITDA Margin | -136.4% | -135.2% | -34.2% | -2.6% | 27.9% |
| Operating Income | (2.57M) | (27M) | (9.93M) | (17.43M) | (28.77M) |
| Operating Margin | -21.8% | -158.1% | -23.0% | -20.1% | -31.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.39M | 3.62M | 2.14M | 14.23M | 9.8M |
| Other Income / Expenses | (17.94M) | (9.76M) | (20.23M) | (12.05M) | 31.7M |
| Income Before Tax | (20.52M) | (36.76M) | (30.16M) | (29.49M) | 2.94M |
| Pre-Tax Margin | -174.1% | -215.2% | -69.7% | -33.9% | 3.2% |
| Income Tax Expense | 12.85K | (11.21M) | 2.29M | 9.21M | 7.04M |
| Net Income | (20.53M) | (25.55M) | (32.46M) | (38.69M) | (4.1M) |
| Net Margin | -174.2% | -149.6% | -75.0% | -44.5% | -4.5% |
| EPS (Basic) | (0.82) | (1.03) | (1.30) | (1.55) | (0.17) |
| EPS (Diluted) | (0.82) | (1.03) | (1.30) | (1.55) | (0.17) |
| Weighted Avg Shares | 24.89M | 24.89M | 24.89M | 24.89M | 23.68M |
| Weighted Avg Shares (Diluted) | 24.89M | 24.89M | 24.89M | 24.89M | 23.68M |
AIRO Group Holdings, Inc. Common Stock
NASDAQ:AIRO
Intrinsic Alpha fair value
Locked
Current Price
$4.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.